We present evidence that a single T cell clone can recognize at least five different overlapping peptides, each with its distinct core structure, in the context of the same major histocompatibility complex (MHC) molecule. Distinct core residues are crucial for triggering the T cell receptor (TCR) in each case. These results suggest that the TCR (a) has multiple sets of contact residues for alternative peptide-MHC ligands, the binding to any one of which can trigger the cell; and/or (b) is able to attach to the peptide-MHC complex in more than one orientation. In this sense, the TCR is a multisubsite structure capable of being stimulated by a variety of peptide ligands associated with the same MHC molecules.
T
CRs recognize an antigen only when the antigen's peptide fragments are lodged in a groovelike site on MHC molecules (1) . How do the TCRs interact with the peptide-MHC complex? The answer is not clear because the crystal structure of the TCR-peptide-MHC complex still has not been solved. In the meantime, several models for the ternary molecular interaction have been proposed in which the CDR3 loops (encoded by the V-(D)-J junctional region) of both chains of the TCR molecule bind the nominal peptide, whereas the germline-encoded CDR1 and CDR2 loops bind the oe helices of the MHC molecule, which flank its peptidebinding groove (1) (2) (3) (4) .
Using variants of each of the three participating molecules of the TCR-peptide-MHC complex, extensive attempts have been made to test these predictions (4) (5) (6) (7) (8) (9) . The results from these studies have neither entirely supported nor contradicted these models; nevertheless, several characteristics of the interacting trimolecular complex have emerged. It thus seems clear that a single peptide-MHC ligand can induce several distinct TCR molecules, with each TCR molecule recognizing a distinct aspect of the peptide in the MHC groove. Different TCR molecules displaying specificity for the same peptide-MHC ligand may interact with different and overlapping residues of the peptide (4) (5) (6) (7) (8) . In addition, studies with MHC mutants at the residues pointing inward along the wall of the peptide-binding groove of the MHC molecule showed that different TCRs displaying identical specificity for the ligand were differentially affected by such mutant MHC molecules (8) . These results emphasize that alterations of the particular conformation of the peptide-MHC complex, induced by the association of the peptide with the altered peptidebinding groove, can result in loss of recognition. Taken together, these results indicate strict constraints in interactions between the TCR molecule and the peptide-MHC complex.
However, how precise are the requirements for peptide structure, distribution of charge and hydrophobicity for a peptide to be a stimulatory one for a given TCR? Can only a single sequence from the antigen associated with a given MHC molecule meet the constraints of TCR recognition? We have asked this question by using a previously reported panel of I-A arestricted sperm whale myoglobin (SWM) 1 peptide 110-121-specific T cell hybridomas (10, 11) . The approach used was to truncate this determinant from one end so as to abrogate T cell recognition but to retain MHC binding, extend the determinant at the other end, and then examine mutations in the new peptide that could restore TCR recognition.
We now report T hybrid CJM4-16 (from the above mentioned panel of T hybrids) could be stimulated by five different peptides presented by I-A d. Different core residues are crucial for triggering the TCR in each case. These results were obtained by (a) using a set of 180 unique peptides derived by substituting every residue, one by one, in the truncated and extended peptide 105-116 with 15 other amino acids; and (b) further analysis of the core structure of three of the six stimulatory mutants of peptide 105-116. Our findings have important implications for models of TCR interaction with peptide-MHC ligands, and they suggest that the TCR is a multisubsite structure capable of being stimulated by a variety of peptide ligands presented by the same MHC molecule.
Materials and Methods

Mice
Mice were obtained from The Jackson Laboratory (Bar Harbor, ME).
Antigens and Peptides
SWM was obtained from Accurate Chemicals & Scientific Corp. (Westbury, NY). SWM peptides 110-121, 105-118, and 105-116 were synthesized and HPLC purified, as described previously (10) (11) (12) . SWM peptide 105-116 and all series of mutant peptides were synthesized on polyethylene pins followed by cleavage into 96-weU plates (10) (11) (12) . Bulk SWM peptide 105-116 and variants D109, Vl12, II14, and Ll14 were synthesized on pins, as well as by conventional methods by Cambridge Research Biochemicals, Inc. (Wilmington, DE). The G107, G108, and Pl13 variant peptides used to define the cores of these mutants (see Fig. 3 ) were synthesized in bulk (5 rag) on the pins. Mass spectroscopic analysis done on 16 of the 24 peptides used in Fig. 3 showed the expected molecular mass and 15 of the 16 peptides consisted of a single product. OVA peptide 323-339 was synthesized as described earlier (13) .
Generation of T Cell Hybrids
The cloned T cell hybridoma CJM4-16 was derived from continuously growing SWM peptide 110-121-specific T cell lines, as described previously (10, 11) . Briefly, T cell blasts from antigenspecific cell lines were fused with the ~-fl-variant of BW5147 as a fusion partner and cloned by limiting dilution in the presence of SWM or its peptides, 110-121, and 105-118 (10, 11) . The antigenreactive hybrids were analyzed for function and TCK V~ expression. The hybrid CJM4-16 was further subcloned by limiting dilution and analysis for antigen specificity.
Specificity Assays
T Cell Hybrids. T hybridoma cells (5 x 104) were cultured with various concentrations of a given peptide with 5 x 10 s irradiated BALB/c (I-A a, I-E d) spleen calls as APCs in 0.2 ml supplemented DMEM (Ftow Laboratories, Ayrshire, Scotland). All cub tures were done in triplicate, except those with the 180 variants of peptide 105-116, which were done in single wells for a given dose of peptide in each experiment. The culture supematants collected 24 h later were assayed for IL-2 activity with the Ib2/Ib 4-dependent cell line, HT-2, as described earlier (10, 11 
Binding of Peptides to 1-/t d
I-A d was affinity purified from cell lysates of A20 lymphoma cells using anti-I-A a mAb MKD-6 (13) . OVA peptide 323-339 was radiolabeled with 12sI using the chloramine T method. Peptides were tested for binding to ]-A d as measured by their capacity to inhibit the binding of *2SI-radiolabeled OVA peptide 323-339, as described previously (13) .
Results
Panels of I-Aa-restricted SWM peptide 110-121-specific T call hybridomas (10, 11) have been reported previously. The minimal core of the peptide determinant recognized by this panel of T hybrids includes amino acids 110-118. The "core" of a peptide determinant is defined as the minimal residues required for both (a) binding to MHC molecules and (b) interacting with the TCR molecule (11) . By removing the two amino acids essential for interaction with the TCR from the minimal core, we generated a truncated-core peptide that could still bind the MHC molecule but not stimulate the T cell population. SWM peptide 105-116 is such a truncated-core peptide for T cell hybrids that recognize SWM peptide 110-121, where the original stimulating core is peptide 110-118. (14) exerted by the extra NH2-terminal sequence 105-109 was demonstrated by the fact that peptide 105-118 was found to be highly stimulatory ( Fig. 1 ).
Pet
Six Mutants of the Truncated-core Peptide 105-116 are Stimulatory to T Hybrid CJM4-16 and Subclone CJM4-16-4
In the next series of experiments, every amino acid within peptide 105-116 was substituted, one by one, with 15 alter- (10, 11) . AU cultures were performed in tripLicate in 0.2 ml. Supernatants from these cultures were then used to assay proliferation of HT-2 cells as described before (10, 11) and in Materials and Methods, and the data are expressed as means + SE of each triplicate culture. The mean _+ SE value for medium controls for this experiment was 1.09 _+ 0.37 (x10-3). Fig. 3 for Table 1 B. The stimulation of CJM4-16 is depicted as + + + when proliferation of HT-2 cell is 15-fold or more than the background (medium control), + + when it is between 5-10 times the background, + when it is 3-5 times the background, and +/-when proliferation is 2-3 times the background. The first peak of G-108 mutants.
native amino acids, thus creating 180 unique peptides. Response to the 180 peptides was examined for cloned T hyhridoma CJM4-16 (core: 110-118) and its subclone, CJM4-16-4, to ensure that all responses were definitively caused by a single T cell. The results from a representative of three experiments for T hybrid CJM4-16-4, at the optimal peptide concentration (7 #M) are shown in Fig. 2 A and were nearly identical to those obtained with CJM4-16 (data not shown). Surprisingly, it was found that several singly substituted analogues of truncated-core peptide 105-116 could trigger the SWM peptide 110-121-specific T hybridoma CJM4-16 or its subclone and this pattern of stimulation was repeated in each experiment studied at three peptide concentrations (see legend of Fig. 2 A) . Fig. 2 Note that several other clones within our panel of SWM ll0-121-specific CD4 T hybrids recognized a different pattern of mutant peptides, while certain other T hybrids were not stimulated by any of the variants of peptide 105-116 (data not shown). Table 1 ).
Stimulatory Variants of Peptide 105-116 Bind to Ill a Within the Same Range as the Nonstimulatory 105-116
Analysis of the Core Structure of the Stimulatory Mutants of p105-116
Three of six stimulatory mutants of the nonstimulatory peptide 105-116 were selected to analyze the core structure recognized within the mutant peptides. The core regions within the G-107, G-108, and P-113 mutant peptides were studied by using three series of 12-mer peptides, sequentially traversing the sequence 100-118 with G always always at position 107 or 108, respectively, or spanning region 102-120, with P at positions 113 (see Fig. 4) .
The results depicted for T hybrid CJM4-16-4 ( Fig. 3) clearly show a surprising "dual-core" pattern of response within each of the three series of overlapping mutant peptides that were tested (Fig. 3) . The response of the T hybrid was assayed as described in Fig. 1 . K-102 is not required for binding to MHC I-A d (see Table 1 ). be pointed out that each of these structures is different from the core structure in the native core sequence 110-118 (Fig. 4) . We predicted residue K-102 of the core 102-113-[G108] (Fig. 4) to be a TCR contact residue of the core 102-113-[G108] since the COOH-terminal positively charged residue R-118 was the TCR-interacting for the core 110-118. It is clear from Table 1 B that K-102 is not required for MHC binding. Substitution of K-102 with A-102 results in complete loss of the ability of the variant peptide 102-113-[G108] to activate the T hybrid CJM4-16 (Fig. 5) . Thus, we propose that the NH2-terminal positive charge at K102 is important for stimulation of T hybrid CJM4-16 by core 102-113-[G108].
Discussion
The current report shows that a single TCR molecule can be stimulated by at least five essentially "different" peptides, each with a distinct core structure, in the context of the same MHC molecule. It demonstrates that single amino acid alterations of a nonstimulatory I-Ad-binding peptide can generate stimulator), peptides for the I-Aa-restricted T hybrids such as CJM4- . Furthermore, we demonstrate that the region 100-121 of SWM binds the MHC I-A a in several different registers; one register, 110-121, which was used as the immunogen, is stimulatory, but the other registers, 105-116 or 102-113, are nonstimulatory. However, several mutants of 105-116 and 102-113 are able to stimulate the CJM4-16-4 T cell; these stimulatory mutant peptides, despite sharing three residues with peptide 110-121, seem essentially very different in charge and hydrophobicity distribution.
Are The crystal structures of the class II molecule and several peptide-MHC class I molecules clearly show that (a) the peptide is lodged in a groovelike site on the MHC molecules, where the walls of the groove are formed by two ol helices and the floor by the 3-pleated sheets encoded by the MHC molecule; and (b) the orientation of the peptide in this groove is fixed and thus the NH2 terminus of all peptides interacts with one end and the COOH terminus with the other end of the groove (14) (15) (16) . However, what can be said about the orientation of the TCR molecule interacting with its ligand, the peptide-MHC complex? It was recently reported that the TCR is oriented over the peptide-MHC complex in such a way that the TCK c~ chain contacts the ol helix formed by the 3 chain of the class II molecule and the TCR ~ chain contacts the class II ol chain (4) . In a different system, using mutants of MHC and TCR molecules, a reverse orientation of the TCR was reported earlier by Janeway and colleagues (17) with the TCR o~ chain contacting the class II c~ chain. Each of these experiments implies that a given TCK interacts with its peptide-MHC ligand in only a single orientation, albeit opposite.
It was recently shown that alteration of a single-charged residue elicited a TCR with a complementary alteration in charge in a specific residue within the CDR3 region (4). These elegant experiments made two important points: (a) there is relevant and direct contact between the nominal peptide and the CDR3 region of the TCR molecule (4, 18) ; and (b) formation of an essential charge interaction between specific residues of the TCK and the peptide is important and of much greater significance than TCK-MHC interaction, which is less demanding (4, 19) .
Since the interaction of the TCR with its ligand(s) involves hydrophobic and/or H bond interactions with the side chains of the peptide residues and/or salt bridges between residues with opposite charges on the peptide and the TCR, respectively (1, 4) , a consideration of the sequences of the different core peptides shown in Fig. 4 suggests the following nonmutually exclusive possibilities:
Recognition by a Single TCR Through Multiple Sets of Contact Residues
(a) The strongly charged residues within the stimulatory sequences are not only qualitatively and quantitatively different, but also occupy different positions relative to the COOH or the NH2 terminus (Fig. 4) . Thus, the peptides 103-114- (c) A third possibility has been postulated earlier (21) , that each of the peptides is able to stimulate the TCR by virtue of its ability to somehow adopt a configuration within the MHC binding site that is equivalent in its constellations of charge, hydrophobicity, and shape (the "equivalence" or mimicry hypothesis). Although it cannot be ruled out, the physical and chemical topography of amino acid residues in these varied peptides do not seem to favor this possibility. The stimulatory peptides have qualitatively and quantitatively different charges, as well as completely different positions of hydrophobic centers (as discussed above).
It has recently been shown that individual T cell clones are able to express two functional TCR ol chains (22) . We have cloned and sequenced the oe and 3 chains of T hybrid CJM4-16 by the PCR. Our results show the expression of a single c~ chain in clone CJM4-16 (Nanda, N. K., R. Fairhurst, and E. Sercarz, unpublished data), thus confirming that it is a single TCR that shows stimulation with a diverse set of peptides in the context of the same MHC molecule.
A Single TCR May be Able to Use Two Opposite Orientations to Recognize its Ligands
(a) The positively charged, carboxy-terminal K-118 in peptide 110-121 has been shown earlier by us to participate in interacting with the TCR of CJM4-16 (11) . In this report, we show that the NH2-terminal K-102 in 102-113-[G108] is not required for binding to MHC (Table 1 B) , but is important for triggering the TCR molecule (Fig. 5) . If, as suggested by Brown et al. (15) and Davis and Chien (23) , the peptide does not switch orientation in the groove of the class II molecule, R-118 (COOH-terminus in core 110-118) and K-102 (NH2 terminus in core 102-113-[G108]) could play a role in TCR-ligand interaction with the same specific negatively charged residue on the TCR only if the TCR switches its orientation by 180 ~ . This interpretation is supported by the fact that only a single negatively charged residue appears in the o~ and ~ sequences of the CDK3 regions of the CJM4-16-4 TCR (Nanda, N. K., K. Fairhurst, and E. Sercarz, unpublished data). However, it is relevant to note that there are other stimulatory peptides (e.g., 103-114-[Pl13]), which have no positive charge, indicating that this is not a sine qua non for reactivity (see below).
(b) Likewise, peptide 110-121 possesses a highly hydrophobic sequence A-I-I at its NH2 terminus and two of these hydrophobic residues, 110-A and 111-I in peptide 110-121, have been shown previously by us to be important for interaction with the TCR of CJM4-16 (11) . The identical hydrophobic se- (24) were found to be not only comparable in the antiparallel ol and 3 chains of I-A a, but also seemed to be symmetrically opposed, per the class II structure described recently (15) . These residues are 79-G, 76-H, 72-A, and 69-Q in the oe chain and 85-G, 81-H, 73-A, and 82-N in the B chain. Although the residue numbers are different, the relative position along the helices are equivalent. That a single TCR can interact with the same MHC in a variety of ways has also been suggested in a recent report (19) .
In conclusion, our experiments reveal that, notwithstanding the general rule of exquisite antigen specificity of a TCR, the CJM4-16 TCR can be triggered by at least five different peptides in the context of the same MHC molecule. That TCR recognition as a rule may exhibit multispecificity is not only supported by the multispecificity exhibited by CJM4-16-4, but also by a previous report showing recognition of two different peptides by a T cell clone (25) . It is of interest to note that in the latter case, at least one positively charged residue was critical for the ability of each peptide to stimulate the same TCR. Recognition of allogeneic MHC molecules by a single T cell clone specific for a nominal antigen is another example showing the potential multispecificity of a TCR molecule (26) (27) (28) (29) .
To summarize, our results, reminiscent of polyfunctional Igs, where a single immunoglobulin could bind several structurally different haptens at different subsites within the antigencombining site of the antibody molecule (30) , suggest that the TCR may have a similar multisite structure capable of being stimulated by a variety of peptides associated with a given MHC.
